Header Logo

Connection

DANIEL D KARP to Non-Randomized Controlled Trials as Topic

Back to Details
This is a "connection" page, showing publications DANIEL D KARP has written about Non-Randomized Controlled Trials as Topic.
DANIEL D KARP
Connection Strength
0.046
Non-Randomized Controlled Trials as Topic
  1. Phase I Study of Everolimus, Letrozole, and Trastuzumab in Patients with Hormone Receptor-positive Metastatic Breast Cancer or Other Solid Tumors. Clin Cancer Res. 2021 03 01; 27(5):1247-1255.
    View in: PubMed
    Score: 0.046
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.